Abstract CT103: Phase I study of LHC165 ± spartalizumab (PDR001) in patients (pts) with advanced solid tumors von Curigliano, Giuseppe, Jimenez, Miguel Martin, Shimizu, Toshio, Keam, Bhumsuk, Meric-Bernstam, Funda, Rutten, Annemie, Glaspy, John, Parikh, Nehal S., Ising, Mary, Hassounah, Nadia, Wu, Jincheng, Xu, Kun, Choudhry, Somesh, Garralda, Elena

Volltext